Pancreatic Cancer Research

ResearcherUniversity of FloridaNo recent work listed

Dinesh Thummuri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6027-0999; OpenAlex author ID A5049022053. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 2 papers

Papers 2

  1. XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. Co-author DOI 10.1073/pnas.2116764119↗
  2. Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL-Specific Degrader DT2216. Co-author DOI 10.1158/1535-7163.mct-21-0474↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Patrick W. Underwood · 2 shared papers, 2022 · strength 0.25
  2. Jose Gilberto Trevino · 2 shared papers, 2022 · strength 0.25
  3. Daohong Zhou · 2 shared papers, 2022 · strength 0.25
  4. Daniel R. Principe · 1 shared paper, 2022 · strength 0.13
  5. Thao D. Pham · 1 shared paper, 2022 · strength 0.13
  6. Suneel Deepak Kamath · 1 shared paper, 2022 · strength 0.13
  7. Ajay Nmn Rana · 1 shared paper, 2022 · strength 0.13
  8. Hidayatullah G. Munshi · 1 shared paper, 2022 · strength 0.13
  9. Guangrong Zheng · 1 shared paper, 2022 · strength 0.12
  10. Andrea N. Riner · 1 shared paper, 2022 · strength 0.12
  11. Sajid Ullah Khan · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.